217 related articles for article (PubMed ID: 27808105)
21. Role of EZH2 in oral squamous cell carcinoma carcinogenesis.
Zhao L; Yu Y; Wu J; Bai J; Zhao Y; Li C; Sun W; Wang X
Gene; 2014 Mar; 537(2):197-202. PubMed ID: 24424512
[TBL] [Abstract][Full Text] [Related]
22. miR‑543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5.
Wang L; Chen W; Zha J; Yan Y; Wei Y; Chen X; Zhu X; Ge L
Oncol Rep; 2019 Sep; 42(3):973-990. PubMed ID: 31322243
[TBL] [Abstract][Full Text] [Related]
23. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
[TBL] [Abstract][Full Text] [Related]
24. The Multifarious Functions of Pyruvate Kinase M2 in Oral Cancer Cells.
Kurihara-Shimomura M; Sasahira T; Nakashima C; Kuniyasu H; Shimomura H; Kirita T
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257458
[TBL] [Abstract][Full Text] [Related]
25. RAN and YBX1 are required for cell proliferation and IL-4 expression and linked to poor prognosis in oral squamous cell carcinoma.
Che X; Liu M; Li D; Li Z; Guo J; Jia R
Exp Cell Res; 2021 Sep; 406(2):112767. PubMed ID: 34364882
[TBL] [Abstract][Full Text] [Related]
26. Oncogene SRSF3 suppresses autophagy via inhibiting BECN1 expression.
Zhou L; Guo J; Jia R
Biochem Biophys Res Commun; 2019 Feb; 509(4):966-972. PubMed ID: 30654935
[TBL] [Abstract][Full Text] [Related]
27. The RBP1-CKAP4 axis activates oncogenic autophagy and promotes cancer progression in oral squamous cell carcinoma.
Gao L; Wang Q; Ren W; Zheng J; Li S; Dou Z; Kong X; Liang X; Zhi K
Cell Death Dis; 2020 Jun; 11(6):488. PubMed ID: 32587255
[TBL] [Abstract][Full Text] [Related]
28. microRNA expression profiles in oral squamous cell carcinoma.
Soga D; Yoshiba S; Shiogama S; Miyazaki H; Kondo S; Shintani S
Oncol Rep; 2013 Aug; 30(2):579-83. PubMed ID: 23708842
[TBL] [Abstract][Full Text] [Related]
29. MTFP1 overexpression promotes the growth of oral squamous cell carcinoma by inducing ROS production.
Xiao T; Sun J; Xing Z; Xie F; Yang L; Ding W
Cell Biol Int; 2020 Mar; 44(3):821-829. PubMed ID: 31814213
[TBL] [Abstract][Full Text] [Related]
30. Baicalein inhibits the growth of oral squamous cell carcinoma cells by downregulating the expression of transcription factor Sp1.
Gao Z; Zhang Y; Zhou H; Lv J
Int J Oncol; 2020 Jan; 56(1):273-282. PubMed ID: 31746368
[TBL] [Abstract][Full Text] [Related]
31. Identification and validation of potential novel biomarkers for oral squamous cell carcinoma.
Zhang M; Chen X; Chen H; Zhou M; Liu Y; Hou Y; Nie M; Liu X
Bioengineered; 2021 Dec; 12(1):8845-8862. PubMed ID: 34606406
[TBL] [Abstract][Full Text] [Related]
32. SRSF3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of Cancer-Specific Energy Metabolism in Colon Cancer Cells.
Kuranaga Y; Sugito N; Shinohara H; Tsujino T; Taniguchi K; Komura K; Ito Y; Soga T; Akao Y
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30279379
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma.
Tokuzen N; Nakashiro K; Tanaka H; Iwamoto K; Hamakawa H
Oncotarget; 2016 Jan; 7(3):2343-53. PubMed ID: 26497678
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
35. Roles of FGFR in oral carcinogenesis.
Xie X; Wang Z; Chen F; Yuan Y; Wang J; Liu R; Chen Q
Cell Prolif; 2016 Jun; 49(3):261-9. PubMed ID: 27218663
[TBL] [Abstract][Full Text] [Related]
36. Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?
Grimm M; Cetindis M; Lehmann M; Biegner T; Munz A; Teriete P; Kraut W; Reinert S
J Transl Med; 2014 Jul; 12():208. PubMed ID: 25048361
[TBL] [Abstract][Full Text] [Related]
37. Identification of Akt1 as a potent therapeutic target for oral squamous cell carcinoma.
Nakashiro K; Tanaka H; Goda H; Iwamoto K; Tokuzen N; Hara S; Onodera J; Fujimoto I; Hino S; Hamakawa H
Int J Oncol; 2015 Oct; 47(4):1273-81. PubMed ID: 26315674
[TBL] [Abstract][Full Text] [Related]
38. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
[TBL] [Abstract][Full Text] [Related]
39. Decreased brain-expressed X-linked 4 (BEX4) expression promotes growth of oral squamous cell carcinoma.
Gao W; Li JZ; Chen SQ; Chu CY; Chan JY; Wong TS
J Exp Clin Cancer Res; 2016 Jun; 35(1):92. PubMed ID: 27297407
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneous ribonucleoprotein K and thymidine phosphorylase are independent prognostic and therapeutic markers for oral squamous cell carcinoma.
Wu CS; Chang KP; Chen LC; Chen CC; Liang Y; Hseuh C; Chang YS
Oral Oncol; 2012 Jun; 48(6):516-22. PubMed ID: 22321252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
